Brooks Laboratories loss decreased by 81.90% in (Q1) FY 2020-21

Source

Team Infinities:

Brooks Laboratories Limited NSE Symbol:BROOKS, BSE Security Code:533543 has declared its 1st(first) quarter un-audited Standalone financial report from the month of April, 2020 to the month of June, 2020; for the fiscal year 2020-21.

Revenue Reported by Brooks Laboratories Limited for First Quarter FY, 2020-21
Current Quarter (April, 2020 - June, 2020) Previous Quarter (January, 2020 - March, 2020) Corresponding Quarter (April, 2019 - June, 2019)
12.58 19.03 16.89
Calculated Revenue of Brooks Laboratories Limited for First Quarter FY, 2020-21
Current(June, 2020) VS Previous(March, 2020) Current(June, 2020) VS Corresponding(June, 2019)
Change Change % Change Change %
6.45 33.89%(Revenue Decrease) 4.31 25.52%(Revenue Decrease)

Revenue: Brooks Laboratories Limited's financial report shows that the company's revenue decreased by 33.89% in QoQ(Quarter on Quarter) / current quarter(April, 2020 - June, 2020) for revenue decrease of Rs.6.45 crores, as the company posted revenue of Rs.12.58 crores; in compare to previous quarter(January, 2020 - March, 2020) when the company reported revenue of Rs.19.03 crores.
The result also shows that the company's revenue decreased by 25.52% in YoY(Year over Year) / in current quarter(April, 2020 - June, 2020) for revenue decrease of Rs.4.31 crores; in compare to corresponding quarter(April, 2019 - June, 2019) when the company posted revenue of Rs.16.89 crores.

Gross Margin(%) Reported by Brooks Laboratories Limited for First Quarter FY, 2020-21
Current Quarter (April, 2020 - June, 2020) Previous Quarter (January, 2020 - March, 2020) Corresponding Quarter (April, 2019 - June, 2019)
1.73(Negative) 28.64 43.59
Calculated Gross Margin(%) of Brooks Laboratories Limited for First Quarter FY, 2020-21
Current(June, 2020) VS Previous(March, 2020) Current(June, 2020) VS Corresponding(June, 2019)
Change Change % Change Change %
30.37 106.05%(GM Decrease) 45.32 103.98%(GM Decrease)

Gross Margin(%)/ GM: The company's financial report indicates, the company's GM decreased by 106.05% in QoQ(Quarter on Quarter) / current quarter(April, 2020 - June, 2020) for 30.37% GM decrease, as the company reported 1.73% Negative GM; in compare to previous quarter(January, 2020 - March, 2020) when the company reported 28.64% GM.
The result also indicates, the company's GM decreased by 103.98% in YoY(Year over Year) / in current quarter(April, 2020 - June, 2020) for 45.32% GM decrease; in compare to corresponding quarter(April, 2019 - June, 2019) when the company reported 43.59% GM.

EBITDA Reported by Brooks Laboratories Limited for First Quarter FY, 2020-21
Current Quarter (April, 2020 - June, 2020) Previous Quarter (January, 2020 - March, 2020) Corresponding Quarter (April, 2019 - June, 2019)
0.13(Negative) 0.64(Negative) 0.05(Negative)
Calculated EBITDA of Brooks Laboratories Limited for First Quarter FY, 2020-21
Current(June, 2020) VS Previous(March, 2020) Current(June, 2020) VS Corresponding(June, 2019)
Change Change % Change Change %
0.51 79.69%(EBITDA Increase) 0.08 160.00%(EBITDA Decrease)

EBITDA/ Earnings before interest, tax, depreciation and amortization: The company's financial report shows that the company's EBITDA increased by 79.69% in QoQ(Quarter on Quarter) / current quarter(April, 2020 - June, 2020) for EBITDA increase of Rs.0.51 crore, as the company posted Negative EBITDA of Rs.0.13 crore; in compare to previous quarter(January, 2020 - March, 2020) when the company reported Negative EBITDA of Rs.0.64 crore.
The result also shows that the company's EBITDA decreased by 160.00% in YoY(Year over Year) / in current quarter(April, 2020 - June, 2020) for EBITDA decrease of Rs.0.08 crore; in compare to corresponding quarter(April, 2019 - June, 2019) when the company posted Negative EBITDA of Rs.0.05 crore.

Profit and Loss Reported by Brooks Laboratories Limited for First Quarter FY, 2020-21
Current Quarter (April, 2020 - June, 2020) Previous Quarter (January, 2020 - March, 2020) Corresponding Quarter (April, 2019 - June, 2019)
2.89(Loss ) 15.97(Loss ) 3.73(Loss )
Calculated Profit and Loss of Brooks Laboratories Limited for First Quarter FY, 2020-21
Current(June, 2020) VS Previous(March, 2020) Current(June, 2020) VS Corresponding(June, 2019)
Change Change % Change Change %
13.08 81.90%(Loss Decrease) 0.84 22.52%(Loss Decrease)

Profit and Loss / PAT(Profit after Tax): The company's financial report shows that the company's loss decreased by 81.90% in QoQ(Quarter on Quarter) / current quarter(April, 2020 - June, 2020) for loss decrease of Rs.13.08 crores, as the company posted loss of Rs.2.89 crores; in compare to previous quarter(January, 2020 - March, 2020) when the company reported loss of Rs.15.97 crores.
The result also shows that the company's loss decreased by 22.52% in YoY(Year over Year) / in current quarter(April, 2020 - June, 2020) for loss decrease of Rs.0.84 crore; in compare to corresponding quarter(April, 2019 - June, 2019) when the company posted loss of Rs.3.73 crores.

EPS Reported by Brooks Laboratories Limited for First Quarter FY, 2020-21
Current Quarter (April, 2020 - June, 2020) Previous Quarter (January, 2020 - March, 2020) Corresponding Quarter (April, 2019 - June, 2019)
1.17(Negative) 9.07(Negative) 2.31(Negative)
Calculated EPS of Brooks Laboratories Limited for First Quarter FY, 2020-21
Current(June, 2020) VS Previous(March, 2020) Current(June, 2020) VS Corresponding(June, 2019)
Change Change % Change Change %
7.90 87.10%(EPS Increase) 1.14 49.35%(EPS Increase)

EPS /Earning per Share: The company's financial report shows that the company's EPS increased by 87.10% in QoQ(Quarter on Quarter) / current quarter(April, 2020 - June, 2020) for EPS increase of Rs.7.90, as the company posted Negative EPS of Rs.1.17; in compare to previous quarter(January, 2020 - March, 2020) when the company reported Negative EPS of Rs.9.07.
The result also shows that the company's EPS increased by 49.35% in YoY(Year over Year) / in current quarter(April, 2020 - June, 2020) for EPS increase of Rs.1.14; in compare to corresponding quarter(April, 2019 - June, 2019) when the company posted Negative EPS of Rs.2.31.

 


***All amounts are given in Crore Indian Rupees(INR) except EPS (Earnings per share) which are in Indian Rupees(INR) only.***
Gross Margin=Total Revenue from Operations -(Cost of Materials Consumed + Purchases of stock-in-trade - Changes in inventories of finished goods, work-in-progress and stock-in-trade).
Gross Margin%=(Gross Margin / Total Revenue from Operations)*100.
EBITDA=Commission/Interest + Depreciation and Amortization + Tax + Profit/Loss (PAT).
1 Lac = 100,000.
1 Million = 10 Lacs.
1 Crore = 10 Millions.
1 Crore = 100 Lacs.
1 Billion = 1000 Millions.
1 Billion = 100 Crores.

 

Add new comment

Comment Editor

  • No HTML tags allowed.